Alzex Neuropharma Inc.

Alzex Neuropharma Inc.

TRRI - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$1.05K
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Alzex Neuropharma Inc.Alzex Neuropharma Inc.0-45%--0.2

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$1,054.00
Enterprise Value$118,018.00
Earnings per Share$-0.11
Beta-4.12
Outstanding Shares1,505,268

Return

Return on Equity45.41%ROE
Return on Assets-3241.38%
Return on Invested Capital73.36%

Valuation & Multiples

P/E Ratio-0.01P/E Ratio
PEG-0.01PEG
Price to Sales-Price to Sales
Price to Book Ratio-0.0Price to Book Ratio
Enterprise Value to Revenue-
Enterprise Value to EBIT-0.29
Enterprise Value to Net Income-1
Total Debt to Enterprise0.99
Debt to Equity-0.21Debt to Equity

Revenue Sources

No data

Institutional Sentiment (Put/Call)

No data available for the latest quarter.

Institutional Ownership

No data available for the latest quarter.

About Alzex Neuropharma Inc.

11 employees
CEO: Robert W. Rosner

Trinity Resources Inc. operates as a company specializing in mineral exploration and mining development. It primarily concentrates on projects involving gold, silver, and platinum group metals throughout North and South America. The firm...

Questions & Answers